These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1043 related articles for article (PubMed ID: 9042221)

  • 21. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
    Seth D; Shaw K; Jazayeri J; Leedman PJ
    Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of apoptosis by EGF receptor in rat mammary adenocarcinoma cells coincides with enhanced spontaneous tumour metastasis.
    Kaufmann AM; Lichtner RB; Schirrmacher V; Khazaie K
    Oncogene; 1996 Dec; 13(11):2349-58. PubMed ID: 8957076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of EGFR gene fragments with nuclear matrix proteins in high and low metastatic melanoma cell lines.
    Wang ZH; Ding MX; Jin ML; Cheng-Chew SB; Yun JP; Wu BQ; Chew EC
    Anticancer Res; 1999; 19(5B):4349-52. PubMed ID: 10628399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
    Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
    J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
    Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
    Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of integrin alpha5beta1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma.
    Béliveau A; Bérubé M; Rousseau A; Pelletier G; Guérin SL
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2363-72. PubMed ID: 10892885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
    Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
    Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
    Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
    van Dinten LC; Pul N; van Nieuwpoort AF; Out CJ; Jager MJ; van den Elsen PJ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):24-30. PubMed ID: 15623750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2F1 in melanoma progression and metastasis.
    Alla V; Engelmann D; Niemetz A; Pahnke J; Schmidt A; Kunz M; Emmrich S; Steder M; Koczan D; Pützer BM
    J Natl Cancer Inst; 2010 Jan; 102(2):127-33. PubMed ID: 20026813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of SPARC gene in tumorigenic capacity of human melanoma cells].
    Ledda MF; Adris S; Bover L; Bravo AL; Mordoh J; Podhajcer OL
    Medicina (B Aires); 1996; 56(1):51-4. PubMed ID: 8734932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for reverse transformation in multidrug-resistant human neuroblastoma cells.
    Meyers MB; Biedler JL
    Prog Clin Biol Res; 1988; 271():449-61. PubMed ID: 3406013
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.
    Rauth S; Green A; Kichina J; Shilkaitis A
    Br J Cancer; 1998 Jun; 77(12):2215-22. PubMed ID: 9649136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of tumor-associated antigens and kinetic profile of two in vitro human melanoma cell lines.
    Badaracco G; Corsi A; Maisto A; Natali PG; Starace G; Zupi G
    Cytometry; 1981 Sep; 2(2):63-9. PubMed ID: 7285723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD109 expression levels in malignant melanoma.
    Ohshima Y; Yajima I; Kumasaka MY; Yanagishita T; Watanabe D; Takahashi M; Inoue Y; Ihn H; Matsumoto Y; Kato M
    J Dermatol Sci; 2010 Feb; 57(2):140-2. PubMed ID: 20034764
    [No Abstract]   [Full Text] [Related]  

  • 40. Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN.
    Kairiyama C; Slavutsky I; Larripa I; Morvillo V; Bravo AI; Bover L; Podhajcer OL; Mordoh J
    Pigment Cell Res; 1995 Jun; 8(3):121-31. PubMed ID: 7567787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.